2012-12-01
Is paromomycin the drug of choice for eradication of Dientamoeba fragilis in adults?
Publication
Publication
International Journal for Parasitology: Drugs and Drug Resistance , Volume 2 p. 162- 165
Dientamoeba fragilis is a debated protozoan parasite that is often detected in stools of patients with chronic gastro-intestinal complaints. A retrospective follow-up study of a large cohort of patients was performed to better understand the natural course of the infection and possible treatment options. D. fragilis was spontaneously cleared in 41% of untreated cases. With an eradication rate of 98%, treatment with paromomycin appeared more effective than treatment with clioquinol (83%) or metronidazole (57%).
| Additional Metadata | |
|---|---|
| , , , | |
| doi.org/10.1016/j.ijpddr.2012.03.002, hdl.handle.net/1765/67859 | |
| International Journal for Parasitology: Drugs and Drug Resistance | |
| Organisation | Department of Medical Microbiology and Infectious Diseases |
|
van Hellemond, J., Molhoek, N., Koelewijn, R., Wismans, P., & van Genderen, P. (2012). Is paromomycin the drug of choice for eradication of Dientamoeba fragilis in adults?. International Journal for Parasitology: Drugs and Drug Resistance, 2, 162–165. doi:10.1016/j.ijpddr.2012.03.002 |
|
